The method of treatment that a physician will recommend for melanoma greatly depends on the stage of cancer a patient has. For those with early-stage melanoma, surgery is the most commonly recommended treatment. The experts in Moffitt Cancer Center’s Cutaneous Oncology Program have perfected the most current and effective surgical procedures, all of which are performed following plastic surgery principles for the best possible results.
Treatment for later-stage melanoma may be more extensive. Depending on the nature of the melanoma, these treatments can include:
- Chemotherapy – While this form of treatment is not commonly used for melanoma, it may be the most effective option in cases where the cancer has metastasized, or spread to other areas of the body.
- Radiation therapy – A machine delivers high-energy rays to the site of the melanoma to target and kill cancer cells.
- Limb infusion and perfusion – A heated dose of chemotherapy is delivered to the area affected by melanoma. This method of treatment spares healthy areas of the body due to the isolation of the cancerous region.
- Immunotherapy – Medications are used to encourage the immune system to recognize and attack cancer cells.
At Moffitt Cancer Center, our skin cancer program utilizes the skills and experience of a multispecialty team to provide an individualized treatment plan for every patient. This approach allows us to maximize each patient’s likelihood of a favorable outcome while also improving quality of life. Thanks to our robust clinical trials program, some of these unique treatments may include new, advanced procedures that are not yet available elsewhere. Additionally, all Moffitt patients have access to physical, emotional, spiritual and other supportive care services, all under one roof.
To learn more about the way we approach treatment for melanoma at Moffitt Cancer Center, call 1-888-663-3488, or complete our new patient registration form. No referrals are required.
Melanoma
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colon Cancer
- Colorectal Cancer
- Cutaneous Lymphoma (CTCL)
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Oral Cavity (Mouth) Cancer
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer